TY  - GEN
AU  - Sidana,S
AU  - Tandon,N
AU  - Dispenzieri,A
AU  - Gertz,M A
AU  - Buadi,F K
AU  - Lacy,M Q
AU  - Dingli,D
AU  - Fonder,A L
AU  - Hayman,S R
AU  - Hobbs,M A
AU  - Gonsalves,W I
AU  - Hwa,Y L
AU  - Kapoor,P
AU  - Kyle,R A
AU  - Leung,N
AU  - Go,R S
AU  - Lust,J A
AU  - Russell,S J
AU  - Zeldenrust,S R
AU  - Rajkumar,S V
AU  - Kumar,S K
TI  - Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
SN  - 1476-5551
PY  - 2019///0208
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers
KW  - Combined Modality Therapy
KW  - Female
KW  - Humans
KW  - Immunoglobulin Light Chains
KW  - blood
KW  - Immunoglobulin Light-chain Amyloidosis
KW  - Male
KW  - Middle Aged
KW  - Organ Specificity
KW  - Phenotype
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Symptom Assessment
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/leu.2017.286
ER  -